pyrazolanthrone has been researched along with Intraocular Pressure in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, AF; Kim, BJ; Liu, Y; Pang, IH; Silverman, SM; Wordinger, RJ | 1 |
Li, B; Li, Y; Liu, C; Pang, IH; Shen, J; Sun, H; Tang, X; Wang, Y | 1 |
Liu, C; Liu, H; Sun, H | 1 |
3 other study(ies) available for pyrazolanthrone and Intraocular Pressure
Article | Year |
---|---|
In vitro and in vivo neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells.
Topics: Animals; Anthracenes; Apoptosis; Disease Models, Animal; Female; Intraocular Pressure; JNK Mitogen-Activated Protein Kinases; Neuroprotective Agents; Rats, Sprague-Dawley; Reperfusion Injury; Retina; Retinal Diseases; Retinal Ganglion Cells | 2016 |
Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
Topics: Animals; Anthracenes; Cell Count; Cell Survival; Disease Models, Animal; Electroretinography; Glaucoma; Intraocular Pressure; JNK Mitogen-Activated Protein Kinases; Male; Ocular Hypertension; Optic Nerve; Protein Kinase Inhibitors; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells; Tonometry, Ocular | 2011 |
Interference of the apoptotic signaling pathway in RGC stress response by SP600125 in moderate ocular hypertensive rats.
Topics: Animals; Anthracenes; Apoptosis; Caspase 3; Enzyme Inhibitors; In Situ Nick-End Labeling; Intraocular Pressure; JNK Mitogen-Activated Protein Kinases; Male; Ocular Hypertension; Rats; Rats, Wistar; Retinal Ganglion Cells; Signal Transduction; Stress, Physiological | 2011 |